Literature DB >> 28429101

Human circulating and tissue gastric cancer stem cells display distinct epithelial-mesenchymal features and behaviors.

Shengliang Zhang1, Yanna Shang1, Tie Chen2, Xin Zhou1, Wengtong Meng1, Chuanwen Fan3, Ran Lu1, Qiaorong Huang1, Xue Li1, Xu Hong1, Zongguang Zhou3, Jiankun Hu4, Xianming Mo1.   

Abstract

INTRODUCTION: Metastasis is a leading cause of cancer-related-deaths worldwide. Recently, cancer stem cells (CSCs) have been believed to be responsible for tumor initiation and metastasis, but till now, difference of cellular features and behaviors between CSCs from tumor tissues (TCSCs) and circulation (CCSCs) remains largely unknown, which hinders the progression of targeted therapies for metastasis. METHODS AND
RESULTS: Here, we provide the features of circulating gastric cancer stem cells (CGCSCs) isolated from human gastric adenocarcinoma. The CGCSCs and TGCSCs were culture in a same serum free stem cell culture medium, however the morphology are different with each other. EMT-associated markers were measured by Immunofluorescence, Western Blotting, and RT-PCR methods, and the results indicated that the CGCSCs and TGCSCs carry different epithelial-mesenchymal features. And then, proliferation and apoptosis assays revealed that the CGCSCs exhibited characteristics of higher proliferation and resistance to apoptosis in vitro. Soft agar assay and nude mice tumorigenicity assay displayed strong tumorigenicity of CGCSCs. Finally, Matrigel invasion assays and in vivo experimental metastasis assay were also performed, which demonstrated that CGCSCs carry high invasive and metastatic capabilities than TGCSCs.
CONCLUSIONS: As expected, the CGCSCs indeed showed extremely invasive and metastatic properties. They also exhibited distinctive mesenchymal phenotypes, high self-renewal, proliferative capabilities, tumor induction and low apoptosis. Interestingly, CGCSCs show small cell-size than TGCSCs (tissue gastric cancer stem cells). The findings might help us to understand the biological characteristic of CGCSCs deeply, and give light to strategies for cancer therapies.

Entities:  

Keywords:  Apoptosis; Cancer stem cells; Mesenchymal; Metastasis; Proliferative capabilities; Self-renewal

Mesh:

Year:  2017        PMID: 28429101     DOI: 10.1007/s00432-017-2417-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  38 in total

Review 1.  Circulating and disseminated tumor cells.

Authors:  Stephan Braun; Bjørn Naume
Journal:  J Clin Oncol       Date:  2005-03-10       Impact factor: 44.544

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients.

Authors:  Tie Chen; Kun Yang; Jianhua Yu; Wentong Meng; Dandan Yuan; Feng Bi; Fang Liu; Jie Liu; Bing Dai; Xinzu Chen; Fang Wang; Fan Zeng; Hong Xu; Jiankun Hu; Xianming Mo
Journal:  Cell Res       Date:  2011-07-05       Impact factor: 25.617

4.  Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

Authors:  Tanja Fehm; Arthur Sagalowsky; Edward Clifford; Peter Beitsch; Hossein Saboorian; David Euhus; Songdong Meng; Larry Morrison; Thomas Tucker; Nancy Lane; B Michael Ghadimi; Kerstin Heselmeyer-Haddad; Thomas Ried; Chandra Rao; Jonathan Uhr
Journal:  Clin Cancer Res       Date:  2002-07       Impact factor: 12.531

Review 5.  Functional studies on circulating and disseminated tumor cells in carcinoma patients.

Authors:  Catherine Alix-Panabières; Kai Bartkowiak; Klaus Pantel
Journal:  Mol Oncol       Date:  2016-01-18       Impact factor: 6.603

6.  Molecular signature associated with bone marrow micrometastasis in human breast cancer.

Authors:  Ute Woelfle; Jacqueline Cloos; Guido Sauter; Lutz Riethdorf; Fritz Jänicke; Paul van Diest; Ruud Brakenhoff; Klaus Pantel
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

7.  Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Authors:  François-Clément Bidard; Dieter J Peeters; Tanja Fehm; Franco Nolé; Rafael Gisbert-Criado; Dimitrios Mavroudis; Salvatore Grisanti; Daniele Generali; Jose A Garcia-Saenz; Justin Stebbing; Carlos Caldas; Paola Gazzaniga; Luis Manso; Rita Zamarchi; Angela Fernandez de Lascoiti; Leticia De Mattos-Arruda; Michail Ignatiadis; Ronald Lebofsky; Steven J van Laere; Franziska Meier-Stiegen; Maria-Teresa Sandri; Jose Vidal-Martinez; Eleni Politaki; Francesca Consoli; Alberto Bottini; Eduardo Diaz-Rubio; Jonathan Krell; Sarah-Jane Dawson; Cristina Raimondi; Annemie Rutten; Wolfgang Janni; Elisabetta Munzone; Vicente Carañana; Sofia Agelaki; Camillo Almici; Luc Dirix; Erich-Franz Solomayer; Laura Zorzino; Helene Johannes; Jorge S Reis-Filho; Klaus Pantel; Jean-Yves Pierga; Stefan Michiels
Journal:  Lancet Oncol       Date:  2014-03-11       Impact factor: 41.316

Review 8.  Circulating tumor cells: approaches to isolation and characterization.

Authors:  Min Yu; Shannon Stott; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber
Journal:  J Cell Biol       Date:  2011-02-07       Impact factor: 10.539

9.  Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

Authors:  Amir Goldkorn; Benjamin Ely; David I Quinn; Catherine M Tangen; Louis M Fink; Tong Xu; Przemyslaw Twardowski; Peter J Van Veldhuizen; Neeraj Agarwal; Michael A Carducci; J Paul Monk; Ram H Datar; Mark Garzotto; Philip C Mack; Primo Lara; Celestia S Higano; Maha Hussain; Ian Murchie Thompson; Richard J Cote; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2014-03-10       Impact factor: 50.717

10.  Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.

Authors:  Bee Luan Khoo; Soo Chin Lee; Prashant Kumar; Tuan Zea Tan; Majid Ebrahimi Warkiani; Samuel G W Ow; Sayantani Nandi; Chwee Teck Lim; Jean Paul Thiery
Journal:  Oncotarget       Date:  2015-06-20
View more
  4 in total

1.  Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.

Authors:  Deli Mao; Zhijun Zhou; Shenglei Song; Dongsheng Li; Yulong He; Zhewei Wei; Changhua Zhang
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

Review 2.  Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Alicja Forma; Amr Maani; Elżbieta Sitarz; Mansur Rahnama-Hezavah; Elżbieta Radzikowska; Piero Portincasa
Journal:  Cells       Date:  2020-04-23       Impact factor: 6.600

3.  A Bottleneck in Understanding Metastatic Cancer Stem Cell of Peritoneal Seeding from Gastric Cancer: A Null Result in Brief.

Authors:  Xin-Zu Chen; Xiao-Hai Song; Xiao-Long Chen; Chang-Chun Li; Xian-Ming Mo; Jian-Kun Hu
Journal:  J Cancer       Date:  2017-09-16       Impact factor: 4.207

4.  Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.

Authors:  Hua Zhou; Abdul Mondal; Aleksandra Dakic; Lama Alhawas; Xuefeng Liu; Zhixu He
Journal:  Biomed Res Int       Date:  2018-02-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.